![Theis Kipling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Theis Kipling
Chief Executive Officer at
BIOVICA INTERNATIONAL AB
Net worth: 209 594 $ as of 31/05/2026
Profile
Theis Kipling is currently Chief Executive Officer at Biovica International AB since 2026.
Formerly, Mr. Kipling was Chief Commercial Officer at Devyser Diagnostics AB from 2022 to 2026 and Chief Commercial Officer at Atlas Antibodies AB.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2024 | 20,809 ( 0.12% ) | 209 594 $ | 31/05/2026 |
Theis Kipling active positions
| Companies | Position | Start |
|---|---|---|
| BIOVICA INTERNATIONAL AB | Chief Executive Officer | 01/05/2026 |
Former positions of Theis Kipling
| Companies | Position | End |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Corporate Officer/Principal | 01/05/2026 |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Health Technology |
Biovica International AB
 Biovica International AB BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes blood-based biomarker assays | Health Technology |
Devyser Diagnostics AB
 Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
- Stock Market
- Insiders
- Theis Kipling
